Partners Capital Investment Group, LLP Abb Vie Inc. Transaction History

Partners Capital Investment Group, LLP

  • $5.87 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024
SELL
$137.6 - $154.97 $86,412 - $97,321
-628 Reduced 13.57%
4,001 $620,000
Q3 2023

Nov 14, 2023
BUY
$133.59 - $154.65 $368,174 - $426,215
2,756 Added 147.14%
4,629 $689,000
Q2 2023

Aug 14, 2023
BUY
$132.51 - $164.9 $248,191 - $308,857
1,873 New
1,873 $252,000

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Partners Capital Investment Group, LLP Portfolio

Follow Partners Capital Investment Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners Capital Investment Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Partners Capital Investment Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email